BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 30479461)

  • 1. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
    Cabrero-de Las Heras S; Martínez-Balibrea E
    World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression and role of CXC chemokines in colorectal cancer.
    Verbeke H; Struyf S; Laureys G; Van Damme J
    Cytokine Growth Factor Rev; 2011; 22(5-6):345-58. PubMed ID: 22000992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of the prognosis and immune infiltration for CXC chemokines in colorectal cancer.
    Yang X; Wei Y; Sheng F; Xu Y; Liu J; Gao L; Yang J; Sun X; Huang J; Guo Q
    Aging (Albany NY); 2021 Jul; 13(13):17548-17567. PubMed ID: 34233297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer.
    Yu L; Yang X; Xu C; Sun J; Fang Z; Pan H; Han W
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107077. PubMed ID: 33068862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment.
    Susek KH; Karvouni M; Alici E; Lundqvist A
    Front Immunol; 2018; 9():2159. PubMed ID: 30319622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway.
    Ruiz de Porras V; Bystrup S; Martínez-Cardús A; Pluvinet R; Sumoy L; Howells L; James MI; Iwuji C; Manzano JL; Layos L; Bugés C; Abad A; Martínez-Balibrea E
    Sci Rep; 2016 Apr; 6():24675. PubMed ID: 27091625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of CXC chemokines and their receptors in cancer.
    Vandercappellen J; Van Damme J; Struyf S
    Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.
    Korbecki J; Kojder K; Kapczuk P; Kupnicka P; Gawrońska-Szklarz B; Gutowska I; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging role of CXC chemokines and their receptors in cancer.
    Vinader V; Afarinkia K
    Future Med Chem; 2012 May; 4(7):853-67. PubMed ID: 22571611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer.
    Lyu L; Zheng Y; Hong Y; Wang M; Deng Y; Wu Y; Xu P; Yang S; Wang S; Yao J; Zhang D; Guo Y; Lyu J; Dai Z
    Int Immunopharmacol; 2020 Oct; 87():106797. PubMed ID: 32702599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis.
    Furuya M; Suyama T; Usui H; Kasuya Y; Nishiyama M; Tanaka N; Ishiwata I; Nagai Y; Shozu M; Kimura S
    Hum Pathol; 2007 Nov; 38(11):1676-87. PubMed ID: 17707463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CXC group chemokines in lung cancer development and progression.
    Spaks A
    J Thorac Dis; 2017 Apr; 9(Suppl 3):S164-S171. PubMed ID: 28446981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members.
    Guo K; Feng G; Yan Q; Sun L; Zhang K; Shen F; Shen M; Ruan S
    Mol Med Rep; 2019 Dec; 20(6):4791-4802. PubMed ID: 31702806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue.
    Oladipo O; Conlon S; O'Grady A; Purcell C; Wilson C; Maxwell PJ; Johnston PG; Stevenson M; Kay EW; Wilson RH; Waugh DJ
    Br J Cancer; 2011 Feb; 104(3):480-7. PubMed ID: 21285972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chemokine/chemokine receptor signature potentially predicts clinical outcome in colorectal cancer patients.
    Mitchell A; Hasanali SL; Morera DS; Baskar R; Wang X; Khan R; Talukder A; Li CS; Manoharan M; Jordan AR; Wang J; Bollag RJ; Singh N; Albo D; Ghosh S; Lokeshwar VB
    Cancer Biomark; 2019; 26(3):291-301. PubMed ID: 31524146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy.
    Mollica Poeta V; Massara M; Capucetti A; Bonecchi R
    Front Immunol; 2019; 10():379. PubMed ID: 30894861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets.
    Bizzarri C; Beccari AR; Bertini R; Cavicchia MR; Giorgini S; Allegretti M
    Pharmacol Ther; 2006 Oct; 112(1):139-49. PubMed ID: 16720046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Novel Biomarkers for Metastatic Colorectal Cancer Using Angiogenesis-Antibody Array and Intracellular Signaling Array.
    Chung S; Dwabe S; Elshimali Y; Sukhija H; Aroh C; Vadgama JV
    PLoS One; 2015; 10(8):e0134948. PubMed ID: 26258407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
    Engl T; Relja B; Blumenberg C; Müller I; Ringel EM; Beecken WD; Jonas D; Blaheta RA
    Life Sci; 2006 Mar; 78(16):1784-93. PubMed ID: 16263140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.